| Field | Specification |
|---|---|
| Target | |
| Antigen | |
| Alternative names | CD32; CD32 antigen ; CD32B; CDw32; Fc fragment of IgG; low affinity II; receptor for (CD32); Fc fragment of IgG; low affinity IIb; receptor ; Fc fragment of IgG; low affinity IIb; receptor (CD32); Fc fragment of IgG; low affinity IIb; receptor for (CD32); Fc fragment of IgG; low affinity IIb; receptor for; Fc gamma receptor IIB; Fc gamma RII; Fc gamma RIIB; Fc-gamma RII; Fc-gamma RII-b; Fc-gamma-RIIb; FCG2; FCG2B_HUMAN; Fcgr2; FCGR2B; FCRII; FcRII-b; IGFR2; IgG Fc receptor II beta; IgG Fc receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II; Low affinity immunoglobulin gamma Fc region receptor II-b; Ly-17; Lym 1; Lymphocyte antigen 17 |
| UniProt # | |
| Host | |
| Clonality | |
| Isotype | |
| Reactivity | |
| Applications | |
| Immunogen | Synthesized peptide derived from the Internal region of Human CD32-B/C. |
| Conjugate | |
| Source | This product is a polyclonal antibody purified from rabbit antiserum. |
| Purification | |
| Form | Liquid |
| Storage | |
| Storage buffer | |
| Catalog no. (Mfr.) | |
| Main SKU |
Product Overview
Research Use OnlyFCGR2B is a research-grade antigen target for which this antibody provides selective detection in commonly studied model systems.
Validated Applications
| Western Blot (WB) | 1:500-1:2000 |
|---|---|
| ELISA (ELISA) | 1:20000 |
Key Specifications
| Clonality | Polyclonal |
|---|---|
| Host Species | Rabbit |
| Isotype | IgG |
| Conjugate | Non-conjugated |
| Purification | Antigen affinity purification |
| Catalog No. | CSB-PA005208 |
| Alternative Names | CD32; CD32 antigen ; CD32B; CDw32; Fc fragment of IgG; low affinity II; receptor for (CD32); Fc fragment of IgG; low affinity IIb; receptor ; Fc fragment of IgG; low affinity IIb; receptor (CD32); Fc fragment of IgG; low affinity IIb; receptor for (CD32); Fc fragment of IgG; low affinity IIb; receptor for; Fc gamma receptor IIB; Fc gamma RII; Fc gamma RIIB; Fc-gamma RII; Fc-gamma RII-b; Fc-gamma-RIIb; FCG2; FCG2B_HUMAN; Fcgr2; FCGR2B; FCRII; FcRII-b; IGFR2; IgG Fc receptor II beta; IgG Fc receptor II-b; Low affinity immunoglobulin gamma Fc region receptor II; Low affinity immunoglobulin gamma Fc region receptor II-b; Ly-17; Lym 1; Lymphocyte antigen 17 |
Immunogen / Antigen
Synthesized peptide derived from the Internal region of Human CD32-B/C. (Antigen species: Human)
Storage & Handling
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
Safety
For Research Use Only (RUO). Not intended for diagnostic, therapeutic, or veterinary use. Handle according to standard laboratory biosafety guidelines. Avoid skin and eye contact. Dispose of waste in accordance with local regulations.
This antibody has been validated for: Western Blot, ELISA. For each application, follow the recommended dilutions on the product datasheet and optimize empirically for your sample type.
WB:1:500-1:2000, ELISA:1:20000
This antibody has been confirmed reactive against: the species listed on the datasheet. Cross-reactivity with other species may occur due to sequence homology but is not guaranteed without independent validation.
Synthesized peptide derived from the Internal region of Human CD32-B/C.
Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. Avoid repeated freeze-thaw cycles. Centrifuge vials briefly before opening. Dilute immediately before use.
Customization & Add-ons: Can’t find the antibody you need—or require a custom format for your assay? We can help you source the best match or support custom antibody solutions for diverse research needs, including species and isotype selection, conjugations and labeling (e.g., HRP/AP, biotin, fluorophores), purification grade options (Protein A/G, affinity purified), formulation preferences (buffer selection, carrier-free, glycerol-free), custom concentrations and aliquoting, low-endotoxin options for cell-based work, and application-focused QC/validation support (project dependent). Click Talk to a Scientist to submit a request, email us at support@biohippo.com, or explore our Research Services for additional support—our team will follow up with feasibility details and next steps.
